VHL vitasora health limited

cancer treatment $6m mkt cap looks cheap, page-3

  1. 22,120 Posts.
    lightbulb Created with Sketch. 20
    quiet thread

    good sign shows stock is yet to be discovered by hotcopperites
    and stock is flying under the radar

    should see a big rerate when the market catches on to the huge potential fee/royalty

    "If exercised, Transgene may receive up to €700 million, plus royalties. Any funds Transgene were to receive upon exercise of this option during the term of the Virax Co-X
    -Gene™ technology Sub-licence would result in payments under the licence"


    Again that payment would be about $1.075 BILLION in AUD terms and even a few % of that to VHL would be many bags on current market cap

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.8¢
Change
0.001(3.70%)
Mkt cap ! $48.11M
Open High Low Value Volume
2.8¢ 2.8¢ 2.7¢ $85.93K 3.069M

Buyers (Bids)

No. Vol. Price($)
1 300000 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 1231056 3
View Market Depth
Last trade - 16.10pm 31/07/2025 (20 minute delay) ?
VHL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.